Associated Papers
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Lavoro A et al.
International Journal of Oncology, 2022
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
Chou WC et al.
International Journal of Biological Sciences, 2016
27994516 (PubMed )
Supplement: ijbsv12p1523s2.pdf
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Karami F et al.
Biomed Research International, 2013
Hereditary ovarian cancer.
Russo A et al.
Critical Reviews in Oncology/hematology, 2009
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
Fackenthal JD et al.
Nature Reviews. Cancer, 2007
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.
Kringen P et al.
Bmc Cancer, 2005
BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization.
Tong D et al.
Clinical Chemistry, 1999
Select a paper to view details